Why Secondary Amenorrhea Happens and How to Treat It

Secondary amenorrhea is the loss of menstrual periods for three or more consecutive cycles in someone who previously menstruated normally. It affects roughly 3 to 4 percent of reproductive-age women and sits apart from primary amenorrhea, which describes periods that never started in the first place.1PubMed. Evaluation and management of adolescent amenorrhea The causes range from everyday shifts in energy balance and stress to hormonal disorders and structural problems inside the uterus, and the condition often signals something worth investigating beyond the missing period itself.

How the Brain Controls the Menstrual Cycle and How That Signal Gets Disrupted

Your menstrual cycle depends on a signaling chain that starts deep in the brain. A small region called the hypothalamus releases a hormone called GnRH in pulses, which tells the pituitary gland to release LH and FSH, which in turn prompt the ovaries to mature an egg and produce estrogen and progesterone. When anything disrupts those GnRH pulses, the whole chain can stall and periods stop.

The most common form of secondary amenorrhea is functional hypothalamic amenorrhea, or FHA, and its root cause is usually some combination of physical stress, psychological stress, or not eating enough to meet your body’s energy demands. These stressors alter a signaling molecule called kisspeptin, which is one of the main drivers of GnRH pulses.2PubMed. Stress, kisspeptin, and functional hypothalamic amenorrhea Research has confirmed that even in women with FHA, kisspeptin is still being released in bursts and is still linked in time to LH pulses, meaning the reproductive system has not shut down permanently. It has just been dialed way down.3PubMed Central. Kisspeptin and LH pulsatility in patients with functional hypothalamic amenorrhea That distinction matters because it means the condition is reversible once the underlying stressor is addressed.

Energy Availability and the Athlete Connection

The single most common thread in FHA is not having enough energy left over after exercise for your body’s basic functions. When caloric intake falls short of what you burn, the body treats reproduction as non-essential and diverts resources elsewhere. This imbalance was originally described as part of the “female athlete triad,” a pattern linking low energy availability, menstrual disruption, and weakened bones.4PubMed Central. Female Athlete Triad and Relative Energy Deficiency in Sport (REDs): Nutritional Management The concept has since expanded into what researchers call Relative Energy Deficiency in Sport, or RED-S, which recognizes that the consequences of low energy availability affect far more than just three body systems.5PubMed Central. The Female Athlete Triad/Relative Energy Deficiency in Sports (RED-S)

The pathway involves metabolic hormones that act as fuel gauges. Leptin, produced by fat tissue, signals that energy stores are adequate. Ghrelin, produced mainly by the stomach, signals hunger. In amenorrheic athletes, leptin tends to be lower and ghrelin higher compared with athletes who still menstruate, even after accounting for differences in body weight.6PubMed Central. Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study These hormonal shifts are linked to suppressed LH pulsatility, connecting the dots between what you eat, how much you move, and whether your brain keeps cycling.7PubMed Central. Higher ghrelin and lower leptin secretion are associated with lower LH secretion in young amenorrheic athletes compared with eumenorrheic athletes and controls

A useful way to think about it: the problem is not exercise per se. Plenty of women train intensely and menstruate normally. The problem is when the gap between calories consumed and calories burned leaves too little energy for everyday physiology. A recreational runner eating well below her needs can lose her period just as readily as an elite endurance athlete. Weight and body-fat percentage alone are unreliable predictors because the energy deficit is what matters, and two people at the same weight can have very different energy balances.

When Stress Alone Is the Trigger

You do not need to be an athlete for FHA. Psychological and psychosocial stressors can suppress GnRH pulses on their own. The contributing factors include perfectionism, mood disorders such as depression and anxiety, adverse life events, and relationship conflicts.8PubMed. Psychosocial stress in women with functional hypothalamic amenorrhea and potential implications for cardiovascular disease risk Chronic psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, your body’s main stress-response system. When cortisol stays elevated for weeks or months, it can directly inhibit the reproductive hormone chain.

What makes stress-related amenorrhea tricky is that many people do not recognize the level of stress they are under. It is common for someone to insist that nothing has changed in their life, yet a careful conversation reveals perfectionist tendencies, chronic sleep debt, or a cumulative load of small stressors that individually seem manageable but collectively tip the balance. Clinicians experienced with FHA often find that the psychological component is underappreciated relative to the nutritional one.

Causes Beyond Functional Hypothalamic Amenorrhea

FHA accounts for a large share of secondary amenorrhea cases, but it is far from the only cause. A proper workup aims to rule out several other possibilities, some of which require very different treatment.

  • Hyperprolactinemia: Elevated levels of prolactin, the hormone that drives milk production, can shut down ovulation and stop periods. A common cause is a small benign tumor of the pituitary gland called a prolactinoma. Certain medications, particularly some antipsychotics and anti-nausea drugs, can also raise prolactin. Neuroendocrine causes like FHA and hyperprolactinemia together account for a majority of secondary amenorrhea cases.9PubMed Central. Neuroendocrine causes of amenorrhea–an update.
  • Polycystic ovary syndrome: PCOS is one of the most common hormonal disorders in women. It involves elevated androgen levels and irregular or absent ovulation. While PCOS is often discussed in the context of irregular periods rather than total absence, some adolescents and adults with PCOS do develop complete amenorrhea, sometimes because prolonged anovulation and high androgens prevent the uterine lining from responding normally.10JAMA Pediatrics. Primary Amenorrhea as a Manifestation of Polycystic Ovarian Syndrome in Adolescents: A Unique Subgroup?
  • Thyroid dysfunction: Both overactive and underactive thyroid glands can interfere with menstruation. Thyroid hormones affect levels of sex-hormone-binding globulin, prolactin, and GnRH, so even mild thyroid disease can ripple through the reproductive axis.11PubMed. Thyroid hormone receptors and reproduction A simple blood test for TSH is typically one of the first steps in any amenorrhea evaluation.
  • Primary ovarian insufficiency: Sometimes called premature menopause, this occurs when ovarian function declines before age 40, leading to low estrogen and high FSH. It can be caused by autoimmune conditions, genetic factors, or prior chemotherapy or radiation.12PubMed Central. Premature Ovarian Insufficiency. Unlike FHA, primary ovarian insufficiency often cannot be reversed, though intermittent ovarian function sometimes occurs.
  • Uterine scarring: Asherman syndrome is a structural cause in which scar tissue (adhesions) forms inside the uterus, usually after a surgical procedure like a dilation and curettage. The scarring can partially or completely block the uterine cavity, preventing a normal menstrual flow even though hormones are cycling normally.13PubMed. Traumatic hypomenorrhea-amenorrhea (Asherman’s syndrome)

The first step whenever someone presents with missing periods is a pregnancy test, which is the most common cause of secondary amenorrhea in reproductive-age women and the easiest to overlook clinically. After pregnancy is ruled out, blood work for thyroid function, prolactin, FSH, and estradiol usually gives a clear direction for further investigation.

What Missing Periods Do to Your Bones

The consequences of secondary amenorrhea extend well beyond fertility. One of the most significant is bone loss. Estrogen plays a central role in maintaining bone density, and when periods stop because estrogen has dropped, bones begin to weaken. Research consistently shows that amenorrheic women have lower lumbar spine bone density than women who menstruate regularly.14PubMed. Hypergonadotropic amenorrhea and bone density: new approach to an old problem The degree of bone loss depends partly on the cause; FHA-related bone loss is driven by low estrogen plus the metabolic stress of energy deficit, which compounds the problem.

This matters especially in younger women. Your skeleton builds most of its peak bone mass during the teens and twenties. Losing bone during this window is not like losing bone at age 70, because you may never fully make up the deficit. Women who experience prolonged amenorrhea during their peak bone-building years can carry measurably lower bone density into middle age, raising their long-term fracture risk.

Cardiovascular Effects That Surprise Most People

The heart and blood vessel effects of secondary amenorrhea are less well-known but increasingly recognized. A systematic review and meta-analysis of physically active women with secondary amenorrhea found they had lower estradiol, impaired blood vessel function (measured by how well arteries dilate in response to increased blood flow), and a less favorable cholesterol profile compared with women who still menstruated.15PubMed Central. Impact of Secondary Amenorrhea on Cardiovascular Disease Risk in Physically Active Women: A Systematic Review and Meta-Analysis Specifically, total cholesterol, LDL, and triglycerides tended to be higher in amenorrheic women.

Individual studies reinforce this picture. One found that amenorrheic endurance athletes had significantly worse arterial dilation and higher LDL compared with athletes who menstruated regularly, with a graded pattern: the more disrupted the menstrual cycle, the worse the cardiovascular markers.16The Journal of Clinical Endocrinology & Metabolism. Amenorrhea in Female Athletes Is Associated with Endothelial Dysfunction and Unfavorable Lipid Profile There is something counterintuitive about fit, lean athletes having worse cardiovascular biomarkers than sedentary controls, but that is exactly what the data show when estrogen is chronically low. Exercise does not fully protect you from the vascular consequences of estrogen deficiency.

Psychosocial stress may compound the cardiovascular risk further. Women with FHA who also carry high psychological stress loads face a combination of elevated cortisol, low estrogen, and metabolic disruption that researchers are now studying as a potential pathway toward long-term heart disease risk.17PubMed. Psychosocial stress in women with functional hypothalamic amenorrhea and potential implications for cardiovascular disease risk

Treating the Root Cause vs. Treating the Symptoms

Treatment for secondary amenorrhea depends entirely on the underlying cause. For FHA, the most effective intervention is addressing what triggered it: eating more, training less, or reducing psychological stress. Research shows that resumption of menstrual cycles depends heavily on nutritional status, including reaching and maintaining adequate body weight and lean mass.18PubMed Central. Female Athlete Triad and Relative Energy Deficiency in Sport (REDs): Nutritional Management For an athlete, that often means a frank conversation about fueling, which can be emotionally charged when performance and body composition feel central to identity.

Cognitive behavioral therapy has shown striking results for FHA specifically. In a randomized trial, six out of eight women who received CBT resumed ovulating, compared with only one out of eight in an observation-only group.19PubMed. Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy A follow-up trial showed that CBT not only restored ovarian function but also lowered cortisol levels and improved broader metabolic and neuroendocrine markers, things that simple observation did not accomplish.20PubMed Central. Neuroendocrine recovery initiated by cognitive behavioral therapy in women with functional hypothalamic amenorrhea: a randomized, controlled trial CBT in this context targets the attitudes and behaviors fueling the stress, such as perfectionism, rigid dietary rules, and compulsive exercise patterns, and the hormonal recovery appears to follow naturally.21PubMed. Use of cognitive behavior therapy for functional hypothalamic amenorrhea

Hormone Replacement to Protect Bones

When periods do not return quickly enough, or when the underlying cause cannot be reversed immediately, clinicians sometimes consider hormone therapy to protect bones. But not all forms of estrogen work equally here, and this is an area where common practice has sometimes gotten ahead of the evidence.

Birth control pills, which are the most commonly prescribed form of estrogen in young women, have not shown clear bone-protective benefits in FHA. A systematic review and meta-analysis found that oral contraceptive pills and oral conjugated estrogen did not significantly increase bone density at any site in women with FHA. Transdermal estrogen patches, on the other hand, did show meaningful improvements at the lumbar spine and femoral neck.22The Journal of Clinical Endocrinology & Metabolism. Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials A separate systematic review reached a similar conclusion: oral contraceptives and conjugated estrogens failed to raise lumbar bone density, while transdermal estradiol patches showed benefit in adolescents with athletic amenorrhea and anorexia nervosa.23BMJ. Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis

The likely reason for the difference is that oral estrogen undergoes first-pass metabolism in the liver, which lowers IGF-1 (a growth factor important for bone) and raises sex-hormone-binding globulin, blunting the estrogen’s effect on bone. Transdermal delivery skips the liver and delivers a steadier, more physiologic estrogen level. In one trial of patients with anorexia nervosa, a transdermal patch delivering 100 micrograms of estradiol with cyclic progesterone for 18 months increased spine and hip bone density compared with placebo.24PubMed Central. Treatments to Prevent Bone Loss in Functional Hypothalamic Amenorrhea: A Systematic Review and Meta-Analysis

This distinction is worth knowing if your doctor suggests “going on the pill” to address amenorrhea-related bone loss. A birth control pill may bring back a monthly withdrawal bleed, but that bleed is not the same as a real menstrual period driven by ovulation, and it does not appear to protect your skeleton the way transdermal estrogen paired with cyclic progesterone does. It can also mask the problem by creating the illusion that periods have returned when the underlying hormonal axis remains suppressed.

An Adaptive Response, Not Simply a Disease

One perspective that changes how many people think about secondary amenorrhea comes from evolutionary biology. Researchers have argued that reproductive suppression during periods of low energy availability is not a malfunction but an adaptive response. From a biological standpoint, attempting pregnancy when caloric reserves are insufficient could compromise both the mother’s health and her long-term reproductive output. Temporarily shutting down the reproductive axis conserves energy for survival and may improve lifetime reproductive success.25PubMed. Energy metabolism and the evolution of reproductive suppression in the human female

This framing does not mean amenorrhea should be ignored. The bone loss and cardiovascular risks are real regardless of whether the underlying signal is “adaptive.” But it does help explain why the body does this. The reproductive system is not broken; it is responding rationally to a perceived resource shortage. That understanding can actually be therapeutic for some patients, shifting the conversation from “something is wrong with you” to “your body is doing exactly what it’s designed to do in this situation, and we need to change the situation.”

Medication-Induced Amenorrhea

Several classes of medication can cause secondary amenorrhea as a side effect, and these cases are often straightforward to identify once someone thinks to ask about prescriptions. The most well-known culprits are depot medroxyprogesterone acetate (the contraceptive injection) and other progestin-only contraceptives, which commonly cause periods to stop altogether. Certain antipsychotic medications raise prolactin levels enough to suppress the menstrual cycle, mimicking the effect of a prolactinoma. Some antidepressants, anti-seizure drugs, and chemotherapy agents can also disrupt menstruation through various mechanisms.

Iatrogenic causes, meaning those resulting from medical treatment, are discussed alongside pathologic and physiologic causes in reviews of the field.26PubMed Central. Neuroendocrine causes of amenorrhea–an update. The good news is that medication-induced amenorrhea typically resolves after the medication is stopped or changed, though it can take several months for cycles to normalize. If your periods stopped around the time you started a new medication, that connection is worth raising with your prescriber before pursuing an elaborate hormone workup.

When Periods Come Back and When They Do Not

For FHA, the prognosis is generally good when the underlying cause is corrected. Most women who restore adequate energy intake and reduce their stress load will see their periods return within several months, though the timeline varies widely. Some resume cycling within weeks of eating more; others take six months or longer. Factors that affect the timeline include how long the amenorrhea lasted, how severe the energy deficit was, and whether psychological stressors are also being addressed.

For other causes, recovery depends on the diagnosis. Hyperprolactinemia caused by a prolactinoma often responds well to dopamine agonist medications, which shrink the tumor and lower prolactin. Thyroid-related amenorrhea typically resolves with thyroid hormone replacement. PCOS-related amenorrhea may improve with lifestyle changes or medication that addresses insulin resistance. Primary ovarian insufficiency, on the other hand, is usually permanent, and those patients often require long-term hormone therapy for bone and cardiovascular protection rather than cycle restoration.

One common source of confusion involves the return of bleeding versus the return of ovulation. A withdrawal bleed triggered by stopping a course of progesterone, or the monthly bleed on oral contraceptives, is not the same as a genuine ovulatory cycle. True recovery means the hypothalamic-pituitary-ovarian axis is functioning on its own, producing follicle development, ovulation, and a natural luteal phase. For women concerned about fertility, confirming ovulation through cycle tracking, basal body temperature, or progesterone level testing is more informative than simply noting whether bleeding has resumed.